Botanical species · safety record

Erythrina verna

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 genotoxicity assay for Erythrina verna. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erythrina verna Vell.

3Constituent measurements

1Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Isoquinoline alkaloids	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
(+)-alpha-hydroxyerysotrine	Flower	Solvent extraction	—	Unspecified	No resolvable identifier
Erythravine	Flower	Solvent extraction	—	Unspecified	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	chromosome aberration	micronucleus assay	House mouse (as animal)	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

De Bona, A. P., Batitucci, M. C. P., Andrade, M. A., Riva, J. A. R., Perdigao, T. L. Phytochemical and mutagenic analysis of leaves and inflorescences of Erythrina mulungu (Mart. Ex Benth) through the micronucleus test in rodents. Revista Brasileira de Plantas Medicinais, 2012, p. 344-351.
Callejon, Daniel R., Riul, Thalita B., Feitosa, Luis G. P., Guaratini, Thais., Silva, Denise B., Adhikari, Achyut., Shrestha, Ram L. (S)., Marques, Lucas M. M., Baruffi, Marcelo D., Lopes, Joao L. C., Lopes, Norberto P. Leishmanicidal Evaluation of Tetrahydroprotoberberine and Spirocyclic Erythrina-Alkaloids. MOLECULES, 2014, vol. 19, no. 5, p. 5692-5703. DOI
Flausino, Otavio Aparecido, Jr., Pereira, Ana Maria., Bolzani, Vanderlan da Silva., Nunes-de-Souza, Ricardo Luiz. Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety. Biological Pharmaceutical Bulletin, 2007, p. 375-378.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature